Home/Filings/4/0001209191-23-004951
4//SEC Filing

Carter Martha J. 4

Accession 0001209191-23-004951

CIK 0001322505other

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 8:10 PM ET

Size

5.3 KB

Accession

0001209191-23-004951

Insider Transaction Report

Form 4
Period: 2023-01-19
Carter Martha J.
Chief Regulatory Officer
Transactions
  • Award

    Common Stock

    2023-01-19+55,00069,506 total
Footnotes (2)
  • [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% of the shares on January 19, 2024, with the remainder vesting in equal installments every three months thereafter beginning on April 19, 2024 and ending on January 19, 2027.
  • [F2]Represents 3,656 shares of common stock and 65,850 restricted stock units.

Issuer

ALBIREO PHARMA, INC.

CIK 0001322505

Entity typeother

Related Parties

1
  • filerCIK 0001213040

Filing Metadata

Form type
4
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 8:10 PM ET
Size
5.3 KB